Curt LaBelle, MD
Dr. LaBelle has been actively involved in the healthcare industry for 16 years, both operationally and as an investor. He has a long history in pharmaceuticals and ophthalmology, serving as a director at Sirion Therapeutics (developer of Durezol and Zirgan), among others. As an investment manager for the Global Health Investment Fund, Dr. LaBelle evaluates late-stage products for conditions disproportionately affecting low and middle income countries. As a director at Eyenovia, Dr. LaBelle supports business development and financing efforts. Dr. LaBelle earned MD and MBA degrees from Columbia University.
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.